Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Pain, Postoperative 5Prostatic Neoplasms 2Neoplasms 2Agnosia 2Urinary Bladder Neoplasms 1Thoracic Neoplasms 1Neoplastic Cells, Circulating 1Malignant Neoplasm of Abdomen 1Lung Neoplasms 1Gynecological Cancer 1Esophageal Neoplasms 1Diverticular Diseases 1Colorectal Neoplasms 1

Interventions

Carboplatin 15Pemetrexed 8Paclitaxel 6pembrolizumab 5osimertinib 4atezolizumab 4Gemcitabine 4Erlotinib Hydrochloride 4entinostat 3durvalumab 3Cisplatin 3selpercatinib 2pralsetinib 2camrelizumab 2apatinib 2Vinorelbine 2Radiosurgery 2Nivolumab 2Injections 2Gefitinib 2Bevacizumab 2130-nm albumin-bound paclitaxel 2toripalimab 1sotorasib 1sintilimab 1repotrectinib 1pegylated granulocyte colony-stimulating factor 1patritumab 1necitumumab 1napabucasin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Thoracic Neoplasms × Injections, Epidural × Clear all
NCT05993273 2025-07-31

Pain Control After VATS Anatomical Pulmonary Resections

University Hospital Padova

Phase NA Completed
75 enrolled
Thoracic

Lung Neoplasms, Pain, Postoperative, Thoracic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡